All In Biotech

Drug Trial Radar · NCT05740566

Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

A Randomized, Open-label, Phase 3 Study of Tarlatamab Compared With Standard of Care in Subjects With Relapsed Small Cell Lung Cancer After Platinum-based First-line Chemotherapy

Last checked: Nov 19, 2026Latest source record: Jan 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 509 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

509

Actual

Start

May 31, 2023

Primary completion

Jan 29, 2025

Study completion Mar 26, 2028

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Feb 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective is to compare the efficacy of tarlatamab with standard of care (SOC) on prolonging overall survival (OS).

Conditions

  • Small Cell Lung Cancer (SCLC)

Interventions

  • TarlatamabDrug

    Tarlatamab will be administered as an IV infusion.

  • LurbinectedinDrug

    Lurbinectedin will be administered per local SOC.

  • TopotecanDrug

    Topotecan will be administered per local SOC.

  • AmrubicinDrug

    Amrubicin will be administered per local SOC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: From randomization up to minimum of death or primary completion DCO date 29 January 2025; median (min, max) time on the study was 8.6 (0.1, 18.5) months

Locations

223 sites in 31 countries. Site status is shown where the registry gives one.

  • University of South Alabama Mitchell Cancer Institute

    Mobile, Alabama

  • Alaska Oncology and Hematology

    Anchorage, Alaska

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • University of California Los Angeles

    Santa Monica, California

  • Northwestern University

    Chicago, Illinois

  • University of Illinois Chicago

    Chicago, Illinois

  • Indiana University

    Indianapolis, Indiana

  • University of Iowa

    Iowa City, Iowa

  • Pikeville Medical Center

    Pikeville, Kentucky

  • Our Lady of the Lake Cancer Institute

    Baton Rouge, Louisiana

  • Trinity Health Saint Joseph Mercy Ann Arbor

    Ann Arbor, Michigan

  • University of Minnesota Cancer Center

    Minneapolis, Minnesota

  • University of Missouri Health Care

    Columbia, Missouri

  • Summit Medical Group, Overlook Oncology Center

    Summit, New Jersey

  • New York University Grossman School of Medicine and New York University Langone Hospitals

    New York, New York

  • Perlmutter Cancer Center at New York University Langone Hospital----Long Island

    New York, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Northport Veterans Affairs Medical Center

    Northport, New York

  • Sanford Roger Maris Cancer Center

    Fargo, North Dakota

  • Sanford Oncology Clinic and Pharmacy

    Sioux Falls, South Dakota

  • University of Tennessee Medical Center Knoxville

    Knoxville, Tennessee

  • Baptist Cancer Center

    Memphis, Tennessee

  • Virginia Commonwealth University

    Richmond, Virginia

  • Swedish Cancer Institute Medical Oncology

    Edmonds, Washington

  • The Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Instituto Argentino de Diagnostico y Tratamiento IADT

    Buenos Aires, Argentina

  • Sanatorio Allende

    Córdoba, Argentina

  • Cemic

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Hospital Universitario Austral

    Pilar, Buenos Aires, Argentina

  • Sociedad de Beneficencia Hospital Italiano

    Córdoba, Córdoba Province, Argentina

  • Clinica Viedma

    Viedma, Río Negro Province, Argentina

  • Sanatorio Parque SA

    Rosario, Santa Fe Province, Argentina

  • Liverpool Hospital

    Liverpool, New South Wales, Australia

  • Calvary Mater Newcastle Hospital

    Waratah, New South Wales, Australia

  • Monash Medical Centre

    Clayton, Victoria, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • Medizinische Universitaet Graz

    Graz, Austria

  • Universitaetsklinikum Krems

    Krems, Austria

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Jessa Ziekenhuis - Campus Virga Jesse

    Hasselt, Belgium

Showing 40 of 223 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.